Author:
Ilyina Irina V.,Patrusheva Oksana S.,Zarubaev Vladimir V.,Misiurina Maria A.,Slita Alexander V.,Esaulkova Iana L.,Korchagina Dina V.,Gatilov Yuri V.,Borisevich Sophia S.,Volcho Konstantin P.,Salakhutdinov Nariman F.
Funder
Ministry of Science and Higher Education of the Russian Federation
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference24 articles.
1. Global influenza strategy 2019–2030; World Health Organization: Geneva, Switzerland, 2019, https://apps.who.int/iris/handle/10665/311184.
2. Influenza;Krammer;Nat Rev Dis Primers,2018
3. Baloxavir Marboxil: The First Cap-Dependent Endonuclease Inhibitor for the Treatment of Influenza;Yang;Ann Pharmacother,2019
4. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza;Uyeki;Clin Infect Dis.,2019
5. Influenza virus resistance to neuraminidase inhibitors;Samson;Antiviral Res,2013
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献